Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
RGEN | REPLIGEN CORP | Director | $314K | May 16, 2024 | ||
CDAKQ | Codiak BioSciences, Inc. | Chief Technology Officer | Mar 28, 2023 |
Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
---|